Polymethyl methaprylate microspheres in collagen

被引:31
作者
Haneke, E [1 ]
机构
[1] Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands
关键词
D O I
10.1016/j.sder.2004.08.002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Artecoll was developed about 20 years ago and underwent a number of production changes until it recently became FDA approved under the new name of Artefill. This product contains 20% polymethyl methacrylate (PMMA) microspheres with a diameter of 30 to 40 mum, which are suspended in a 3.5% atelo-collagen solution. The PMMA microspheres are now purified and no longer have an electrostatic charge, which in part was the cause for the early granulomatous reactions. Further, PMMA has long been known as bone cement and has been used in cosmetic surgery with a very good safety record. PMMA microspheres are biologically inert and nondegradable. The treatment results are therefore permanent and technical errors as well as incorrect injections will last. Due to the early record of granuloma formation, there is still a debate as to whether this product as well as all other permanent fillers-should be injected for cosmetic reasons or not. With proper indications, excellent injection techniques, and realistic expectations as to what can be expected, this product has now proved to be one of the superior permanent filler substances. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 34 条
[1]   Late-onset granulomatous reaction to artecoll [J].
Alcalay, J ;
Alkalay, R ;
Gat, A ;
Yorav, S .
DERMATOLOGIC SURGERY, 2003, 29 (08) :859-862
[2]  
AUBRONOLIVIER C, 2001, NEWFILL LIPOTROPHY
[3]   INJECTABLE COLLAGEN - A 6-YEAR CLINICAL INVESTIGATION [J].
COOPERMAN, LS ;
MACKINNON, V ;
BECHLER, G ;
PHARRISS, BB .
AESTHETIC PLASTIC SURGERY, 1985, 9 (02) :145-151
[4]  
España A, 2001, DERMATOL SURG, V27, P23
[5]   Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery [J].
Fagien, S .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 103 (02) :701-713
[6]   Treatment of inflamed hypertrophic scars using intralesional 5-FU [J].
Fitzpatrick, RE .
DERMATOLOGIC SURGERY, 1999, 25 (03) :224-232
[7]  
HANEKE E, 2004, EUROPEAN HDB FACIAL
[8]  
Hanke CW, 1998, BAS CLIN DERMATOL, P145
[9]  
Hertzog B., 1997, J MED ESTH CHIR DERM, V24, P253
[10]   Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials [J].
Hofmann, C ;
Schuller-Petrovic, S ;
Soyer, HP ;
Kerl, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :100-102